Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation-Reference-Cited by-同舟云学术

Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation

Published:2019-02-10 Issue:6 Volume:49 Page:636-643
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Steenstraten Iris C.¹,Sebib Korkmaz Kerem¹,Trivedi Palak J.²³⁴⁵,Inderson Akin¹,van Hoek Bart¹^ORCID,Rodriguez Girondo Mar D. M.⁶,Maljaars P. W. Jeroen¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology; Leiden University Medical Centre; Leiden The Netherlands

2. National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre; Birmingham UK

3. University Hospitals Birmingham; Birmingham UK

4. Institute of Immunology and Immunotherapy; University of Birmingham; Birmingham UK

5. Institute of Applied Health Research; University of Birmingham; UK

6. Department of Biomedical Data Sciences; Leiden University Medical Centre; Leiden The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15148/fullpdf

Reference45 articles.

1. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review;Boonstra;J Hepatol,2012

2. An update on primary sclerosing cholangitis;Maggs;Curr Opin Gastroenterol,2008

3. Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation in Japanese registry;Egawa;Am J Transplant,2011

4. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation;Alexander;Liver Transpl,2008

5. Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation;Miki;Br J Surg,1995

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Past, current, and future trends in the prevalence of primary sclerosing cholangitis and inflammatory bowel disease across England (2015–2027): a nationwide, population-based study;The Lancet Regional Health - Europe;2024-09

2. GSK805 inhibits alpha‐smooth muscle expression and modulates liver inflammation without impairing the well‐being of mice;The FASEB Journal;2024-08-19

3. The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms;Cancers;2024-08-07

4. The potential of volatile organic compounds to diagnose primary sclerosing cholangitis;JHEP Reports;2024-08

5. 10.6002/ect.2024.0085;Experimental and Clinical Transplantation;2024-07